PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.\', \'Department of Immunology, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.\', \'Department of Pharmacology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.\', \'ImmunoLingo Convergence Centre, University of Oslo, Oslo, Norway.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/irv.12932
?:hasPublicationType
?:journal
  • Influenza and other respiratory viruses
is ?:pmid of
?:pmid
?:pmid
  • 34751488
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.966
?:rankingScore_hIndex
  • 42
?:title
  • Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all